MF
NVCR icon

Magnetar Financial’s NovoCure NVCR Stock Holding History

Magnetar Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Buy
+10,293
New +$129K ﹤0.01% 994
2023
Q1 		– Sell
-3,296
Closed -$242K – 685
2022
Q4 		$242K Buy
+3,296
New +$248K ﹤0.01% 672
2017
Q2 		– Sell
-15,272
Closed -$124K – 916
2017
Q1 		$124K Buy
+15,272
New +$110K ﹤0.01% 695
2016
Q4 		– Sell
-12,216
Closed -$104K – 275
2016
Q3 		$104K Buy
+12,216
New +$111K ﹤0.01% 530

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Magnetar Financial's NVCR Position: Q1 2026 in Review

Magnetar Financial opened a new position in NovoCure (NVCR) in Q1 2026: 10,293 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #994 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in NVCR as recently as Q4 2022.

Magnetar Financial first reported a position in NVCR in Q3 2016 and has held it in 4 quarters since. The position peaked at $242K in Q4 2022. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Magnetar Financial held 10,293 shares of NovoCure worth $112K as of Q1 2026.
  • NovoCure was a new Magnetar Financial position in Q1 2026.
  • NovoCure made up ﹤0.01% of Magnetar Financial's portfolio in Q1 2026, its #994 holding.
  • Magnetar Financial first reported a position in NovoCure in Q3 2016 and has held it in 4 quarters since.
  • Magnetar Financial's NovoCure position peaked at $242K in Q4 2022.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.